P., G. A., E., E., J., S. A., D., P., Fernández Montes, A., Graña, B., . . . Sastre, J. (2024). Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: The AFEMA phase II randomized trial.
Citación estilo ChicagoP., García Alfonso, et al. Maintenance With 5-FU/LV-aflibercept After Induction With FOLFIRI-aflibercept Versus FOLFIRI-aflibercept Until Progression As Second-line Treatment in Older Adults With Metastatic Colorectal Cancer: The AFEMA Phase II Randomized Trial. 2024.
Cita MLAP., García Alfonso, et al. Maintenance With 5-FU/LV-aflibercept After Induction With FOLFIRI-aflibercept Versus FOLFIRI-aflibercept Until Progression As Second-line Treatment in Older Adults With Metastatic Colorectal Cancer: The AFEMA Phase II Randomized Trial. 2024.